Perspectives on Development and Advancement of New Tuberculosis Vaccines

Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, is responsible for an estimated 1.3 million deaths each year, despite effective treatment being available for the past six decades. Progress in the development and point of care rollout of improved vaccines, diagnostics and treatments has been very slow, and TB remains a neglected global health problem. Moreover, access to available WHO recommended TB diagnostics and treatment regimens for all forms of TB remains a major challenge, especially in low- and middle-income countries, where 80% of annual TB case load occurs [1].

Source: International Journal of Infectious Diseases - February 25, 2024 Category: Infectious Diseases Authors: Christopher da Costa, Christine S Benn, Thomas Nyirenda, Evans Mpabalwani, Harleen M.S. Grewal, Rizwan Ahmed, Nathan Kapata, Peter S Nyasulu, Markus Maeurer, David S Hui, Delia Goletti, Alimuddin Zumla Tags: Perspective Source Type: research